Rezultati

eNauka >  Results >  Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
Title: Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
Authors Passiglia, Francesco; ...; Secen, Nevena; ...; (broj, koautora 36)
Issue Date: 2025
Publication: JOURNAL OF THORACIC ONCOLOGY
ISSN: 1556-0864 Journal of Thoracic Oncology Search Idenfier
Type: Article
Collation: vol. 20 br. 5 str. 614-624
DOI: 10.1016/j.jtho.2024.12.010
WoS-ID: 001504694800007
Scopus-ID: 2-s2.0-85214346225
URI: https://enauka.gov.rs/handle/123456789/985767
Project: AstraZeneca
Amgen
BeiGene
Blueprint Medicines
Boeringher Ingelheim
Gilead
Incyte
Eli Lilly
Merck
MSD
Novartis
Pfizer
Roche
Sanofi
Thermo Fisher Scientific
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

4
SCOPUSTM
5
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.